EUVIMEDEUVIMED entdecken
Crossref

Vinpocetine attenuates myocardial ischemia/reperfusion injury in mice by suppressing oxidative stress, inflammation, and apoptosis

Tianchen Xia, Yichen Qian, Yilong Jiang, Qiang Zhang, Jiahao Pan, Hui Xiong, Jiaxin Zhang, Taotao Yan, Qi Li, Shenjie Zhang, Qingsheng You

Naunyn-Schmiedeberg's Archives of Pharmacology · 20.08.2026

DOI: 10.1007/s00210-026-05821-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, online erschienen am 20.08.2026. Verfasst von Tianchen Xia und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiothoracic Surgery, Affiliated Hospital of Nantong University, Nantong, China. Die Arbeit nennt 60 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Myocardial ischemia-reperfusion injury (MIRI) represents a frequent and serious complication that arises after acute myocardial infarction. During MIRI, the NLRP3 inflammasome exerts a critical function in controlling inflammatory processes. Vinpocetine (VIN) is mainly used as a neuroprotective agent in cerebrovascular diseases, and it exhibits both antioxidant properties and anti-inflammatory activities. Earlier investigations indicated that VIN can suppress NLRP3 inflammasome activation. Nevertheless, its specific contribution to cardiac MIRI and the mechanisms involved have yet to be fully unraveled. The current study sought to examine the cardioprotective actions of VIN in a murine MIRI model and to determine whether the protection is linked to the NLRP3 inflammasome pathway. MIRI was induced in mice through ischemia/reperfusion (I/R) procedures. Cardiac performance and the extent of myocardial damage were assessed via echocardiography, determination of infarct area, measurement of serum cardiac enzymes, evaluation of oxidative stress markers, and analysis of apoptosis-associated protein levels. Findings demonstrated that pretreatment with VIN at a dose of 10 mg/kg substantially ameliorated I/R-triggered impairment of cardiac function, diminished infarct size, lowered circulating creatine kinase (CK) together with lactate dehydrogenase (LDH) concentrations, and potently attenuated oxidative stress as well as cardiomyocyte apoptosis. Moreover, I/R strongly triggered NLRP3 inflammasome assembly and elevated concentrations of its downstream inflammatory factors, while VIN pretreatment effectively prevented these alterations. Further experiments using MCC950, a selective NLRP3 inflammasome inhibitor, showed that MCC950 exerted cardioprotective effects comparable to those of VIN, and co-administration of MCC950 and VIN did not confer additional significant benefits. Observations in the current work imply that heart-protective benefits conferred by VIN occur to a substantial degree via blockade of NLRP3 inflammasome activity. Taken together, pretreatment with VIN reduces the severity of MIRI in the murine model through attenuation of oxidative damage, cellular apoptosis, and inflammation-related cascades, in which suppression of the NLRP3 inflammasome may constitute one key pathway accounting for such beneficial outcomes.

Schlagwörter

Stichwörter der Autor:innen

Cellular apoptosisInflammationMIRINLRP3Oxidative stressVinpocetine

Autor:innen und Institutionen

  • Department of Cardiothoracic Surgery, Affiliated Hospital of Nantong University, Nantong, China.
  • Medical School of Nantong University, Nantong, China.
  • Department of Cardiothoracic Surgery, Affiliated Hospital of Nantong University, Nantong, China. 1085691730@qq.com.
  • Department of Cardiovascular Surgery, Zhongshan Hospital, Fudan University, Fenglin Road 180, Shanghai, 200032, China. Philip_Z918@163.com.
  • Department of Cardiothoracic Surgery, Affiliated Hospital of Nantong University, Nantong, China. yqsyy@ntu.edu.cn.

Zitieren

APA

Xia, T., Qian, Y., Jiang, Y., Zhang, Q., Pan, J., Xiong, H., Zhang, J., Yan, T., Li, Q., Zhang, S., & You, Q. (2026). Vinpocetine attenuates myocardial ischemia/reperfusion injury in mice by suppressing oxidative stress, inflammation, and apoptosis. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-026-05821-9

Vancouver

Xia T, Qian Y, Jiang Y, Zhang Q, Pan J, Xiong H, et al. Vinpocetine attenuates myocardial ischemia/reperfusion injury in mice by suppressing oxidative stress, inflammation, and apoptosis. Naunyn-Schmiedeberg's Archives of Pharmacology. 2026. doi:10.1007/s00210-026-05821-9

BibTeX
@article{Xia2026,
  author = {Xia, Tianchen and Qian, Yichen and Jiang, Yilong and Zhang, Qiang and Pan, Jiahao and Xiong, Hui and Zhang, Jiaxin and Yan, Taotao and Li, Qi and Zhang, Shenjie and You, Qingsheng},
  title = {Vinpocetine attenuates myocardial ischemia/reperfusion injury in mice by suppressing oxidative stress, inflammation, and apoptosis},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2026},
  doi = {10.1007/s00210-026-05821-9}
}
Kostenlos starten →